This page contains health-related information for reference only. It is not medical advice. Read full disclaimer
oncology
In medicine, proton therapy, or proton radiotherapy, is a type of particle therapy that uses a beam of protons to irradiate diseased tissue, most often to treat cancer. The chief advantage of proton therapy over other types of external beam radiotherapy is that the dose of protons is deposited over a narrow range of depth; hence in minimal entry, exit, or scattered radiation dose to healthy nearby tissues.
Proton therapy, also called proton radiotherapy, is a type of particle therapy that uses a beam of protons to irradiate diseased tissue, most often to treat cancer. Its defining advantage over other forms of external-beam radiotherapy comes from the physics of how protons deposit energy: the dose is released over a narrow range of depth, an effect known as the Bragg peak, so there is minimal entry, exit or scattered radiation to the healthy tissue around the target. This allows a higher radiation dose to be delivered to a tumour while significantly reducing the dose to nearby organs at risk. Physicians may therefore choose proton therapy when sparing the surrounding normal tissue cannot be adequately achieved with conventional photon-based radiotherapy and doing so would benefit the patient. Like photon radiation therapy, proton therapy is often used in conjunction with surgery and/or chemotherapy to treat cancer most effectively. There are two main delivery methods. In passive scattering, the earliest commercially available approach, the beam is spread out by scattering devices and then shaped to the tumour with items such as collimators and compensators. In the newer pencil-beam scanning method, a thin beam is swept magnetically across the target so the dose closely conforms to the tumour's shape without custom-milled hardware; many older scattering systems have since been upgraded to pencil-beam scanning. Proton therapy has been in clinical use for over 40 years and is a mature technology, although, as with all radiation, understanding of how it interacts with tumour and normal tissue remains imperfect.
Other clinically reasonable options for the same condition. The right alternative depends on the patient's specific anatomy, comorbidities, and goals — discuss with a treating clinician rather than self-selecting from this list.
Photon (X-ray) radiotherapy
Established, widely available alternative; less precise dose conformity to organs at risk.
When systemic disease dominates the clinical picture.
Specialty-board certifications and facility-level accreditations relevant to this procedure. Verify on the issuer's public register before booking — most issuers publish a searchable directory.
ESMO Designated Centre of Integrated Oncology
Issuer European Society for Medical Oncology
Facility designation for integrated oncology + palliative care services. Useful as a quality signal for cancer centres outside the US JCI/CoC frameworks.
Verify on the issuer's register →ACS Commission on Cancer Accredited Program
Issuer American College of Surgeons
US facility-level accreditation for comprehensive cancer programs. Quality signal for oncology centres.
Verify on the issuer's register →JCI hospital accreditation
Issuer Joint Commission International
Facility-level standards covering patient safety, infection control, governance, and clinical quality. Required by many medical-tourism intermediaries before listing a hospital.
Verify on the issuer's register →Ongoing research studies registered on ClinicalTrials.gov whose intervention involves proton therapy. This is a neutral pointer to public research — not an endorsement, not a recruitment drive, and not medical advice. Trial status changes often; confirm eligibility and current status with the study team via each record.
Showing 5 recent ongoing studies. Source: ClinicalTrials.gov — all matching trials (U.S. National Library of Medicine, public domain). Retrieved 2026-08-02.
Average recovery for Proton Therapy is 0 days. Individual recovery varies — always follow your surgeon’s specific guidance.
Immediate
First 24–48 hours post-procedure. Monitoring, anaesthesia recovery, initial pain management. Most clinics expect you to remain on-site or nearby.
Early recovery
Wound care, swelling or bruising peaks, restricted activity. Typical window for follow-up visits and drain removal if applicable. Travel is usually not advised.
Intermediate recovery
Gradual return to non-strenuous daily activity. Many international patients fly home during this window. Surgeon may require medical clearance for long-haul travel.
Full recovery
Return to full activity, exercise, and work. Final results may still be settling. Final follow-up with local doctor recommended.
Browse all destinations offering Proton Therapy→Detailed cost breakdown →
Proton therapy is a form of particle therapy that uses a beam of protons to irradiate diseased tissue, most often to treat cancer. It is a type of external-beam radiotherapy.
Protons deposit their dose over a narrow range of depth, an effect called the Bragg peak, with little entry, exit or scattered radiation. This lets a higher dose reach the tumour while reducing radiation to nearby healthy organs compared with conventional photon therapy.
Pencil-beam scanning is the newest form of delivery. A thin proton beam is swept magnetically across the target so the dose closely conforms to the tumour's shape. The older method, passive scattering, spreads a wider beam and shapes it with collimators and compensators.
Physicians may choose it when it is important to deliver a higher dose to the tumour while sparing nearby organs at risk, particularly when adequate sparing of normal tissue cannot be achieved with photon-based radiotherapy and the patient would benefit.
Not always. Like photon radiation therapy, proton therapy is often used together with surgery and/or chemotherapy in order to treat cancer most effectively.
No. Proton therapy has been in use for over 40 years and is described as a mature technology, though, as with all radiation treatment, the understanding of how it interacts with tumour and normal tissue is still imperfect.
Other oncology procedures in our registry